SPDR S&P Pharmaceuticals ETF
XPH
XPH
77 hedge funds and large institutions have $261M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 60 increasing their positions, 6 reducing their positions, and 17 closing their positions.
Holders
77
Holders Change
-8
Holders Change %
-9.41%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
60
Reduced
6
Closed
17
Calls
$924K
Puts
$788K
Net Calls
+$136K
Net Calls Change
-$625K
Top Buyers
1 |
1
Goldman Sachs
New York
|
$28.8M |
2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$19.2M |
3 |
3
UBS Group
Zurich,
Switzerland
|
$21.3M |
4 |
4
Morgan Stanley
New York
|
$40.5M |
5 |
PVH
5
Psagot Value Holdings
Tel Aviv,
Israel
|
$10.1M |